Immune evasion continues to limit the effectiveness of cancer immunotherapies. Among emerging regulatory molecules, transfer RNA-derived small RNAs (tsRNAs of 13-48 nucleotides), generated through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback